pproximately 5% of cases of sudden cardiac death occur without underlying heart disease and are classified as idiopathic ventricular fibrillation (VF). 1 In 1992, Brugada and Brugada reported a group of patients with idiopathic VF associated with characteristic electrocardiographic (ECG) findings of right bundle-branch block (RBBB) and ST segment elevation localized in the right precordial leads, 2 and since then Brugada syndrome (BS) has been identified as an important cause of sudden cardiac death, especially in Japan and Southeast Asia, including Thailand. [3] [4] [5] In 2000, we reported 2 cases of BS for the first time in Korea 6 and since than have had 13 more patients with the condition. The aim of the present study was to investigate the clinical features of Korean patients with BS.
Methods
We selected 15 consecutive patients identified as having BS at the Asan Medical Center from June 1998 to April 2002 for retrospective analysis. The diagnostic criteria were the characteristic ECG finding and the clinical events, including syncope and cardiac arrest, in patients without structural heart disease. The characteristic ECG finding was defined as ST segment elevation of more than 0.2 mV localized in the right precordial leads, and only the covedtype of ST elevation was regarded as abnormal (Fig 1) . 7 A flecainide provocation test was performed to confirm the diagnosis (2 mg/kg iv infusion for 10 min). Additional findings such as ST elevation of more than 0.1 mV or transition of the ST segment from saddle-back to coved type after flecainide were regarded as positive (Fig 2) . Signal-averaged electrocardiography (SAECG) was performed to investigate the presence of intraventricular conduction abnormalities. Two of the 3 following criteria for late potentials 8 were regarded as positive: (1) filtered QRS complex duration greater than 120 ms, (2) less than 20 V of signal in the last 40 ms of the filtered QRS complex, and (3) the terminal filtered QRS complex remains below 40 V for longer than 39 ms. Organic heart disease was excluded by the past clinical history, echocardiography, Holter ECG monitoring, treadmill exercise test, thallium myocardial single photon emission computed tomography (SPECT), and in some patients with cardiac magnetic resonance image, cardiac MIBG (methyliodobenzylguanidine) scan, and coronary angiography with an ergonovine stress test to exclude spasm of the coronary artery.
An electrophysiologic study was performed after obtaining informed consent from each patient. Programmed electrical stimulations were performed twice with the diastolic current threshold delivered from the right ventricular apex and outflow tract. Rapid ventricular pacing was performed first until 200 ms, and then up to 2 extrastimuli were delivered at 2 different drive cycle lengths (600 and 400 ms) until reaching the effective refractory period (ERP). Electrical stimulation was limited to the coupling interval of any extrastimulus at or above 200 ms. A positive electrophysiologic study was defined as the induction of VF or sustained ventricular tachycardias requiring electrical cardioversion to terminate the arrhythmia.
The ST segment elevation was divided into 4 patterns (1) coved type, (2) saddle-back type, (3) mixed form (ie, A both patterns manifesting simultaneously), and (4) alternating form (ie, each pattern manifests at a different time) (Fig 3A,B) . If the ST segment elevation disappeared during the follow-up period regardless of the presence of the RBBB pattern, it was defined as 'transient ST normalization', and when both the ST elevation and RBBB pattern disappeared, as 'transient ECG normalization' (Fig 4A,B) . During the follow-up period, patients were considered to have had an arrhythmic event if they had a documented episode of syncopal ventricular arrhythmia or received an appropriate shock from an implantable cardioverter-defibrllator (ICD). Shocks were considered appropriate when ventricular tachycardia or ventricular fibrillation was documented in the stored electrograms of the device or when syncope or dizziness preceded the shock if the electrograms were not available.
Results

Clinical Characteristics
Fifteen cases of BS were enrolled of which 13 (87%) were male patients with a mean age of 44±10 years. Thirteen of the cases (87%) had a clinical manifestation at the time of diagnosis: documented VF in 8, syncope in 2, atypical chest pain in 2, and atypical chest pain with syncope in 1 patient ( Table 1) . The remaining 2 patients 
ECG Characteristics
All 15 patients recorded an ECG with the typical Brugada pattern at the time of diagnosis without a flecainide provocation test. The PR intervals were within normal limits and all showed the RBBB pattern. Coved-type ST elevations was seen in 11 (73%) patients, mixed form in 4 (27%), and none showed the saddle-back type only. The 4 patients with mixed form showed alternation between coved-and saddle-back type in the follow-up ECGs ( Table 2 ). The ST elevation normalized transiently in 13 patients (87%), 10 of whom showed transient complete normalization of the 12-lead ECG. SAECG was performed in 13 patients and 8 had positive late potentials (62%).
Other Examinations
Echocardiography was performed in all patients. One or 2 of treadmill exercise test, thallium myocardial SPECT and coronary angiography were performed in all patients to exclude ischemia. All of these examinations were normal.
Electrophysiologic Study and Flecainide Provocation Test
An electrophysiologic study was performed in all patients except 2 who developed severe hypoxic brain damage after cardiopulmonary resuscitation for VF. VF was induced in 7 (54%) ( Table 3 ) and the flecainide provocation test was positive in 8 (73%) of the 11 patients.
Management and Clinical Progress
The mean follow up period was 19±14 (1-47) months and all patients were alive at the time of this study. The therapeutic plan considered the clinical manifestations, family history of sudden death, and the results of the electrophysiologic study (Table 4 ). An ICD was implanted in all patients presenting with clinical symptoms at the time of diagnosis except for the 2 with severe hypoxic brain damage. VF was induced in 2 asymptomatic patients (No. 14 
Discussion
Transient normalization of the ST segment or entire ECG occurred in most of the present patients. Dynamic ECG variations have been widely reported in patients with BS and these 2 phenomena occur in about half of them. 9, 10 Changes in body temperature and heart rate, respiratory variation, exercise, and a variety of drugs are factors that seem to be related to the ECG variations observed in BS. 11 Frequently, spontaneous ECG changes make it difficult to diagnose BS and many of the patients diagnosed as idiopathic VF or syncope of unknown origin in the past has the condition. According to a recent study, VF and sudden death can occur similarly in those that show sustained ST elevation or transient ST elevation, 12 and therefore, a provocation test using sodium channel blockers is essential for the diagnosis of unexplained VF or syncope. In the present study, 40-50% of the patients had a family history of sudden death, as has been previously reported, 3 which suggests that the provocation test should be carried out in all the family members of a patient with BS. Another ECG characteristic observed in this study was the frequent association of supraventricular arrhythmias; 5 patients (33%) experienced supraventricular arrhythmias during clinical follow-up: paroxysmal atrial fibrillation in 4 and paroxysmal supraventricular tachycardia in 1. This finding suggests that inhomogeneity of abnormal repolarization is not limited to the ventricle and may also involve the atria or atrioventricular node. 13, 14 Therefore, when syncope or cardiac arrest occur in patients with supraventricular arrhythmias and cannot be explained by the arrhythmia, an association with BS should be considered. Recurrence of VF among the patients with an ICD in the present study almost always occurred in those who initially presented with VF, which suggests that the most important point in considering the use of an ICD in BS is the clinical symptoms, especially the initial presentation of VF.
The therapeutic strategy for BS is not well established yet. In general, it is based on the clinical symptoms, results of the electrophysiologic study, family history of sudden death etc. 3, [15] [16] [17] [18] Brugada et al reported the results of 34 months of follow-up of 64 patients in 1998. They found similar possibilities of sudden death between patients with clinical symptoms and those without the symptom (34% vs 24%; p = NS). 9 However, Atarashi et al had different results of a 3-year follow-up of 105 patients. The incidence of arrhythmic events among the symptomatic patients was 25.7%, but only 1.5% in asymptomatic patients (p<0.05). 4 These opposite results make it difficult to determine the therapeutic plan for BS. Recently, Brugada et al suggested a therapeutic guideline, based on the clinical tests and follow-up of 334 patients, 16 in which patients who experienced sudden death or syncope belong to the high-risk group and should receive an ICD. In asymptomatic patients who show spontaneous ECG changes, an electrophysiologic study is recommended and only if significant ventricular arrhythmia is induced is an ICD recommended. Asymptomatic individuals who record an abnormal ECG only after pharmacological challenge should be followed up without further tests such as an electrophysiologic study. The present data confirm the generally accepted view that symptomatic patients with BS have a high rate of arrhythmic events, especially those who initially present as a case of aborted sudden death.
We prescribed quinidine, a vagolytic drug that blocks Ito, for patients who had recurrent ventricular arrhythmias after receiving an ICD because theoretically it should be beneficial and has been shown to exert an antiarrhythmic effect in patients with idiopathic VF, of whom some may actually have BS. 19, 20 However, despite this prophylaxis, most of the patients in the present study developed recurrent ventricular arrhythmias. At present, the general consensus is that there are no specific pharmacologic treatments for preventing sudden death in patients with BS and an ICD is the only effective intervention. 3, 9 Study Limitations The present study investigated a relatively small number of patients who had short follow-up periods because the study was conducted in one institute only. Further long-term follow-up studies are needed to determine the clinical characteristics and long-term prognosis of Korean patients with BS. The present study did not assess the electrophysiologic data of the atrium using program atrial stimulation and SAECG at baseline because most of the supraventricular rhythm episodes developed during the follow-up period. Although we speculate that inhomogeneity of abnormal repolarization exists not only in the ventricle, we need further studies of the electrophysiological properties of the atrium in BS patients.
Conclusions
In Korea, patients with BS show diverse clinical and ECG manifestations. The dynamic nature of the ST segment provides important clue to the diagnosis of BS, but can be a diagnostic pitfall, leading to underdiagnosis of this syndrome. Recurrence of malignant arrhythmia is extremely high in patients who initially present as a case of aborted sudden death, for which the most important therapeutic consideration is an ICD.
